A unique pattern of immune molecules in the cerebrospinal fluid of people with myalgic encephalomyelitis/chronic fatigue syndrome have been discovered, providing insights into the basis for cognitive dysfunction –frequently described by patients as ‘brain fog’– as well as new hope for improvements in diagnosis and treatment.
Read more here

ME & Long COVID patients need telemedicine prescribing flexibility
DEA should amend its proposed rule to ensure access to care